Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
6.94
-0.14 (-1.98%)
Jan 21, 2025, 4:00 PM EST - Market closed
Sage Therapeutics Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Sage Therapeutics stock have an average target of 11.39, with a low estimate of 4.00 and a high estimate of 26. The average target predicts an increase of 64.12% from the current stock price of 6.94.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for SAGE stock from 20 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 16 | 16 | 15 | 16 | 15 | 15 |
| Sell | 1 | 1 | 2 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 20 | 20 | 20 | 20 | 19 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $26 → $9 | Buy | Maintains | $26 → $9 | +29.68% | Jan 2, 2025 |
| Stifel | Stifel | Hold Maintains $10 → $6 | Hold | Maintains | $10 → $6 | -13.54% | Dec 16, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +29.68% | Nov 21, 2024 |
| RBC Capital | RBC Capital | Sell → Hold Upgrades $4 | Sell → Hold | Upgrades | $4 | -42.36% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $14 | Hold | Reiterates | $14 | +101.73% | Nov 20, 2024 |
Financial Forecast
Revenue This Year
43.11M
from 86.46M
Decreased by -50.13%
Revenue Next Year
95.85M
from 43.11M
Increased by 122.32%
EPS This Year
-6.70
from -9.05
EPS Next Year
-3.98
from -6.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 48.1M | 182.8M | 550.2M | |||
| Avg | 43.1M | 95.8M | 161.9M | |||
| Low | 38.0M | 37.9M | 71.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -44.4% | 324.0% | 474.0% | |||
| Avg | -50.1% | 122.3% | 68.9% | |||
| Low | -56.0% | -12.2% | -25.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -6.27 | -0.85 | -1.06 | |||
| Avg | -6.70 | -3.98 | -2.89 | |||
| Low | -7.33 | -5.18 | -4.72 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.